- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07035171
- Original Trial
CABGpreHAB - a Feasibility Study Protocol
CABGpreHAB- Home-based Multimodal Prehabilitation (CABGpreHAB) for Elective Patients Awaiting CABG-surgery - a Feasibility Study Protocol
Patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft (CABG) surgery often face challenges like advanced age, frailty, comorbidities, and physical inactivity. These factors, combined with the physiological and psychological stress of surgery, can hinder postoperative recovery. Traditionally, strategies to improve surgical outcomes focus on the intra- and postoperative periods. However, the pre-surgery waiting period offers a "window of opportunity" for prehabilitation, which aims to enhance patients' functional capacity through exercise, nutrition, and psychological support.
The CABGpreHAB feasibility study evaluates the feasibility of a home-based multimodal prehabilitation intervention for patients awaiting elective CABG surgery. This randomized pilot study compares the intervention plus usual care to usual care alone, assessing feasibility outcomes like recruitment, retention, attrition, fidelity, and adherence. The study aims to optimize a subsequent full-scale randomized controlled trial (RCT) and improve patient outcomes by leveraging the pre-surgery period for prehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Advanced age, frailty, comorbidity, and physical inactivity are often present in patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft surgery (CABG). These characteristics, as well as the physiological impact of having surgery, are significant homeostatic disturbances where patients postoperatively suffer from physical symptoms and a lack of return to independence. Cardiac surgery invariably induces varying degrees of physiological stress, impacting multiple organ systems, and imposes a psychological burden. As age increases, patient complexity and comorbid burden grow more common in patients undergoing cardiac surgery; innovative strategies are required to alleviate the risk of adverse outcomes. Strategies to improve outcomes from surgery and accelerate return to baseline levels have traditionally focused on the intra- and postoperative period, nevertheless, the waiting period before surgery might offer an opportunity for improving the safety and outcome of the surgical intervention and improving patients' motivation in postoperative rehabilitation and recovery time. Prehabilitation is a newly introduced term that reflects a proactive process of enhancing an individual's functional capacity between diagnosis and scheduled surgery, intending to improve the patient's capacity to withstand the upcoming physiologic stress of surgery and thus avoid complications. This period of awaiting surgery is proposed as a "window of opportunity" to address poor nutritional status, low physical fitness, and high emotional distress. The role of multimodal prehabilitation combining exercise training, nutritional optimization, and psychological support, in patients with IHD awaiting CABG surgery, is sparse and unknown in a Danish setting
Objective:
This CABG preHAB feasibility study is conducted to evaluate the feasibility of delivering a homebased multimodal prehabilitation intervention for patients awaiting elective CABG surgery with the purpose to optimize a subsequent full-scale RCT.
Design:
The CABGpreHAB feasibility study is designed as a randomized pilot study, aiming to assess the feasibility of a multimodal prehabilitation intervention plus usual care versus usual care alone in patients awaiting elective CABG surgery. It is an investigator-initiated study designed as an open-label, single-center randomized controlled feasibility study (allocation ratio 1:1) with blinded outcome assessment, designed to assess the method proposed for use in a larger RCT.
Study population:
Patients aged more than 18 years awaiting elective CABG-surgery
Primary outcomes:
Feasibility outcomes include:
Recruitment and retention rates. The recruitment rate will be determined by the number of individuals participating in the study out of those who are eligible/admissible but refuse to participate. First, the investigators will evaluate the number of patients that can be included in the study during the inclusion period. A proportion of 60% or more of patients awaiting elective CABG surgery who are eligible for the study is acceptable. Retention will be assessed by the percentage of participants who remain in the study from the beginning to the end of the study (30 days post-surgery).
Attrition rates. Attrition is defined by the number of individuals who consent to participate in the study but drop out before the end of the intervention period, regardless of group allocation.
Fidelity. Fidelity of delivery of the webcam-based exercise training intervention will be assessed qualitatively by 8-10 semi-structured interviews, the day before surgery, by a research nurse.
Adherence to the interventions will be measured by using the number of telephone counselling and tele-exercise sessions delivered out of the theoretical number that could have been delivered based on the surgical wait time of each participant. Adherence to the home-based tele-exercise training sessions and telephone counselling by assessing the number of sessions applied in the intervention group. This will be collected by the patient's recorded physical activity logbook, by weekly phone calls, and by accelerometer data. Adherence with the prehabilitation program will be assessed against the target of individuals achieving > 70% of the prescribed exercise program (self-reported) + during the study follow-up with phone calls. Inclusion in the CABGpreHAB study must be attractive to at least 30% of eligible patients who meet the inclusion criteria. The interventions must be widely accepted, with at least 70% of included participants completing 70% or more of the planned sessions in the intervention group. Safety of the intervention will be determined based on the number and nature of adverse events (AE).
Secondary outcomes:
Secondary outcomes will assess the patients' responses to the multimodal prehabilitation programme, and data will be collected on explorative outcomes, measured at baseline, the day before surgery and 30 days PO.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dorte Baek Olsen, PhD student
- Phone Number: +4526625705
- Email: dorte.baek.olsen@regionh.dk
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Recruiting
- The Department of Heart and Lung Surgery, Copenhagen University hospital Rigshospitalet
-
Contact:
- Dorte Baek Olsen, PhD student
- Phone Number: +4526625705
- Email: dorte.baek.olsen@regionh.dk
-
Contact:
- Ida Elisabeth Højskov, PhD, RN
- Phone Number: +4535451843
- Email: ida.elisabeth.hoejskov@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Planned to have elective isolated first-time CABG surgery.
- 18 years or older
- Two weeks or more before surgery
- Speaks and understands Danish.
- Gives written informed consent.
Exclusion Criteria:
- Patient with unstable angina pectoris and/ or MI during the last two weeks.
- Left main stem stenosis >50%
- Left ventricular ejection fraction < 35%
- Significant ventricular arrhythmia
- Orthopedic or neurologic preconditions precluding exercise training.
- Inability to attend the prehabilitation program due to physical limitations.
- Patients who have cognitive deficits that would disqualify prehabilitation.
- Severe heart failure, NYHA Class IV
- Lack of capacity to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CABGpreHAB multimodal prehabilitation intervention + usual care
Patients randomized to the multimodal prehabilitation programme will, besides usual care, receive home-based preoperative interventions that consist of: Web-based exercise intervention supervised by skilled physiotherapists and delivered via a tablet. Each session lasts 60 minutes, three times per week for the prehabilitation period. Patients will be instructed to perform daily exercise tasks such as brisk walking and sit-to-stand exercises. Phone call and consultation delivered by a specialised nurse once a week. This consultation will deliver psychosocial support, equipping patients with coping strategies to mitigate stress, anxiety, and depression. Furthermore, nutritional advice will take place at these consultations, as well as advice on smoking cessation and alcohol cessation. |
Multimodal prehabilitation interventions (CABGpreHAB):
|
|
Other: Control group
Participants assigned to the control group will receive usual care.
|
This includes standard information about CABG surgery, pre- and postoperative care, and postoperative physical activity advice.
Patients are either admitted days before or on the day before surgery.
They receive written materials and links to animated videos about preparing for surgery.
This preparation includes counseling with a multidisciplinary team, including a department nurse, a physiotherapist, a cardiac anesthesiologist, and a surgeon.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility outcome: recruitement rate
Time Frame: Through study completition, an average of 1 year
|
Determined by the number of individuals participating in the study out of those eligible during the inclusion period.
|
Through study completition, an average of 1 year
|
|
Feasibility outcome: Attrition rates
Time Frame: Up to 30 days post surgery index
|
Defined by the numbers of individuals who give consent to participate, but drop out before study ends.
|
Up to 30 days post surgery index
|
|
Feasibility outcome: Fidelity
Time Frame: preoperative
|
Fidelity of delivery on the web-based exercise training intervention will be assessed qualitatively by semi-structured interviews
|
preoperative
|
|
Feasibility outcome: Adherence rates
Time Frame: Preoperative
|
Adherence will be assessed by measuring the number of telephone counseling and exercise sessions delivered during the intervention period.
|
Preoperative
|
|
Feasibility outcome: Safety
Time Frame: From enrolement to the day before surgery
|
Safety of the intervention will be determined based on the number and nature of adverse events.
|
From enrolement to the day before surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise capacity
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
6MWT measures total walking distance in meters completed in six minutes
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Muscle strength
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
30 seconds sit-to-stand measured by numbers of sit-to-stands in 30 seconds
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Muscle strength handgrip
Time Frame: At baseline and preoperative
|
Measured in kilograms using a hand-held dynamometer
|
At baseline and preoperative
|
|
Bodycomposition
Time Frame: At baseline and preoperative
|
Using a Bioelectrical Impedance Analyzer (BIA), body composition estimation: fat mass in kilograms, Fat mass as a percentage of weight, Fat-free mass in kilograms, Fat-free mass as a percentage of weight |
At baseline and preoperative
|
|
Nutritional status
Time Frame: At baseline and preoperative
|
Weight and height combined to report BMI in kg/m^2, and Screened by the NRS2002 score |
At baseline and preoperative
|
|
Daily physical activity
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
SENS motion accelerometer measures minutes of physical activity as steps, Cyckling running Standing Laying |
Three times: at baseline, preoperative and 30 days post surgery index
|
|
HRQOL
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
The Questionnaire SF-12 measures overall health status
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Heart-specific QoL
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
The Questionnaire HeartQoL measures health-related quality of life in patients with ischemic heart disease
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Anxiety
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
The State-Trait Anxiety Inventory Questionnaire measures two disitnc types of anxiety
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Depression
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
The PHQ-4 Questionnaire measures depression and anxiety
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Sense of coherence
Time Frame: At baseline
|
The SOC-13 Questionnaire assesses an individual´s ability to manage stress and maintain health
|
At baseline
|
|
Self-efficacy/self-management
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
The PAM13 Questionnaire assesses an individual's knowledge, skill, and confidence for self-management
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Tobacco uses status
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
Self-Reported Questionnaire
|
Three times: at baseline, preoperative and 30 days post surgery index
|
|
Alcohol uses status
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
|
Self-Reported Questionnaire
|
Three times: at baseline, preoperative and 30 days post surgery index
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications postoperatively
Time Frame: From date of surgery and up to 30 days postopetively.
|
Rates of pneumonia, atelectasis, hemorrhage, cardiac arrhythmias, and delirium will be measured postoperatively
|
From date of surgery and up to 30 days postopetively.
|
|
ICU-LOS
Time Frame: From date and time of surgery until the date and time of discharge to the ward.
|
ICU-LOS will be calculated in hours
|
From date and time of surgery until the date and time of discharge to the ward.
|
|
LOS
Time Frame: From date of surgery until date of discharge from the ward
|
LOS will be calculated in days
|
From date of surgery until date of discharge from the ward
|
|
DAOH30
Time Frame: From date of surgery and up to 30 days postopetively.
|
DAOH30 will be calculated in days
|
From date of surgery and up to 30 days postopetively.
|
|
Participating in Cardiac rehabilitation
Time Frame: At 30 days postoperatively
|
Participation will be calculated in percentage
|
At 30 days postoperatively
|
|
Bloodtest
Time Frame: At baseline and postoperatively day 4
|
HGB measured in mmol/l Albumin measured in g/l CRP measured in mg/l Creatinine measured in micromol/l
|
At baseline and postoperatively day 4
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ida E Hoejskov, PhD, Department of Heart Disease, Rigshospitalet, Copenhagen University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rigshospitalet Copenhagen
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.